Mason Morfit’s Bio-Techne TECH Stock Holding History

Mason Morfit’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-248,016	Closed	-$4.28M	–	15
2013 Q2	$4.28M	Buy	+248,016	New	+$4.12M	0.04%	14

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mason Morfit's TECH Position: Q3 2013 in Review

Mason Morfit sold out of Bio-Techne (TECH) in Q3 2013, closing a stake of 248,016 shares — an estimated $4.28M sold.

Mason Morfit first reported a position in TECH in Q2 2013 and held it in 1 quarter. The position peaked at $4.28M in Q2 2013. 248 funds tracked by Wall St. Rank hold TECH as of Q3 2013.

Mason Morfit reported no remaining Bio-Techne position as of Q3 2013 after selling out during the quarter.
Mason Morfit sold 248,016 Bio-Techne shares in Q3 2013, an estimated $4.28M.
Mason Morfit first reported a position in Bio-Techne in Q2 2013 and held it in 1 quarter.
Mason Morfit's Bio-Techne position peaked at $4.28M in Q2 2013.
248 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2013.

Based on ValueAct Holdings's 13F filing for Q3 2013, filed 14 Nov 2013.